SpringTide Ventures — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

Benefits ScienceJul 2018SEC filingmedium confidence

Boston, US

Dimitris Bertsimas(Manager)Stephen Sofoul(President and Manager)Sidney Mann(Vice President and Manager)

BoardRufus Clyde Parker(Manager)

Board seatYiannis Monovoukas· per SEC Form D · $3M raise · filed Jul 2019

TheraPten BiosciencesJan 2018SEC filingmedium confidence

BiotechKelowna

Athanasios Alevizopoulos(Chief Executive Officer)Harvey Lalach(Chief Business Officer)Yiannis Monovoukas(Director)Kyriakoulis Paganis(Director)

Board seatYiannis Monovoukas· per SEC Form D · $500K raise · filed Jan 2018

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.